In August 2018, Jeffrey Katzenberg, the former chairman of Walt Disney Studios, set out to build a new kind of streaming service. He recruited Meg Whitman, the former CEO of eBay and Hewlett-Packard, to run it. Together they raised $1.75 billion, the largest pre-launch war chest a media startup had ever assembled, before a single subscriber had opened the app. The company, Quibi, launched in April 2020 with A-list talent and a genuinely novel piece of technology called Turnstyle that let viewers rotate their phones between portrait and landscape without losing the frame. Six months later, it shut down. Its content library was eventually sold to Roku for less than $100 million, a fraction of what had gone into building it.

Quibi's collapse is usually explained by a list of separate mistakes: a launch during a pandemic that emptied commutes, no free tier, no ability to share clips on social media, a subscription price competing against free alternatives. Each of those is a real, documented factor, and no single one fully accounts for what happened. But underneath that list sits a strategic problem that no amount of capital could resolve on its own: Quibi never established a sufficiently compelling reason for viewers to choose its particular form of short-form entertainment over the alternatives already competing for those same minutes and hours, whether that was TikTok during a commute or Netflix in the evening.

The company had the money to build almost anything before it had answered that question, and no subsequent spending could retroactively answer it after the product was already in the market.This is the uncomfortable story most founders skip on the way to a pitch deck. Funding gets treated as the scoreboard, the thing that proves a startup is winning. The evidence, and a long list of expensively funded failures, suggests something narrower and more useful: capital and market position solve different problems, and mistaking one for the other is expensive.

Money Can Extend a Startup's Life. It Rarely Saves the Business Underneath.

CB Insights has spent over a decade tracking why venture-backed startups die, drawing on founders' own post-mortem accounts. Its most recent analysis covers 431 venture-backed companies that shut down since 2023, of which 385 had a clear enough public record to identify a cause. Seventy percent of those 385 cited running out of capital, but CB Insights is explicit that this is almost always the final cause of death, not the root problem.

The more telling reasons sit underneath it: 43 percent cited poor product-market fit, 29 percent cited bad timing, and 19 percent cited unsustainable unit economics, figures that add up to well over 100 percent because companies frequently named more than one cause. Across the full set of 431 companies, CB Insights' own reporting puts collective funding at $17.5 billion, with an $11 million median raise, a $48 million average pulled up by a long tail of heavily funded failures, and a median of 22 months between a company's last fundraise and its shutdown.

What that dataset actually demonstrates is narrower than "positioning beats funding." It shows that capital extends the period during which a company can search for a viable business model; it does not guarantee that the search will succeed. Olive, a healthcare AI startup, and Convoy, a freight brokerage, illustrate a different limitation of capital. Olive had raised roughly $850 million and reached a $4 billion valuation at its peak; Convoy had raised more than $1 billion and reached a $3.8 billion valuation. Both wound down within two weeks of each other in October 2023, but not for identical reasons.

Convoy's CEO pointed to an unprecedented freight-market collapse combined with sharp monetary tightening, a demand-side and macroeconomic shock more than a positioning failure. What the two cases share is simpler and more damning for the funding-first narrative: neither company's capital, however substantial, could substitute for a business model that worked once conditions turned against it. It financed the distance between the company's founding and its reckoning, not an escape from the reckoning itself.

Positioning Is Not the Same Thing as Product-Market Fit

The two terms get used almost interchangeably in founder conversations, and they are not the same thing. Product-market fit asks whether customers genuinely want what a company is offering, whether enough of them have a problem this specific product solves well enough to pay for repeatedly. Positioning asks a different question: why should a customer understand this offering as distinct from the alternatives already competing for their attention?

A startup can, in principle, have real product-market fit and still lose to a better-positioned competitor who has convinced the market it owns a category the first company arguably built. The two do not simply run in sequence, product-market fit first and positioning second. They reinforce each other: positioning shapes which customers discover a product, what expectations they bring to it, and how willing they are to try and pay for it, while product-market fit gives a position something real to defend once a competitor tries to contest it.

In 1980, the marketing strategists Al Ries and Jack Trout published Positioning: The Battle for Your Mind, built on the claim that marketing is fundamentally a battle of perceptions, fought inside a customer's limited attention before it is fought anywhere else. The framework argues that companies compete not only through what they build but through the mental category customers use to understand what they have built, which is why a superior product or a deeper war chest does not automatically translate into a superior position in the customer's mind.

Quibi is a case where that framework applies cleanly: the company never resolved whether it was competing for the minutes people spend on short-form video or the hours they spend on prestige television, and it ended up owning neither position clearly, regardless of what else went wrong alongside it.

The Smaller Player's Advantage

If capital and positioning are genuinely different levers, the clearest evidence should be startups that won against better-funded, better-known incumbents specifically because of how they positioned themselves. One of the most studied cases is Taobao's rise against eBay in China. By 2007, eBay was one of the largest online marketplaces in the world, with far more capital and a proven global playbook than any local challenger.

Harvard Business School professor Felix Oberholzer-Gee has pointed to Taobao's strategy as an example of choosing ground an incumbent struggles to follow onto: rather than copying eBay's model, Taobao built its marketplace around mechanisms designed to reduce the perceived risk of transacting with a stranger online, an unfamiliar act for most Chinese consumers at the time, including differences from eBay in registration, escrow, and seller reputation systems that research comparing the two platforms has documented.

EBay eventually withdrew from the Chinese market entirely. The episode is better read as a case of deliberate local adaptation and differentiated positioning working together than as proof that positioning alone defeated a better-funded rival; pricing, partnership choices, and regulatory dynamics were part of the story too. But the strategic-fit difference, building an ecosystem suited to local buying behavior rather than a cleverer brand, was central enough that HBS still teaches the case as one.

Earlier research from IMD's Global Center for Digital Business Transformation, surveying nearly 1,000 executives across 15 industries, found a consistent asymmetry. Executives at incumbent companies named their biggest advantages as access to capital, trusted brands, and an existing customer base. Executives at startups named speed, agility, and a culture of experimentation as theirs. The study does not draw a conclusion about which side wins; the implication for a startup is nonetheless uncomfortable: trying to beat an incumbent primarily on capital risks competing on one of the exact dimensions where the incumbent already holds the advantage. A startup that instead finds ground the incumbent's own strengths make it reluctant to defend does not need comparable capital to hold that ground.

Clayton Christensen's The Innovator's Dilemma offers one explanation for why incumbents keep leaving that ground open even when the threat is visible in hindsight. Large, well-run companies listen closely to their most profitable customers and rationally direct resources toward serving them better, which is precisely what makes them structurally slow to take a smaller, less profitable segment seriously until a challenger has already claimed it. Christensen's theory should not be reduced to a positioning strategy: disruption describes a particular competitive trajectory, entrants targeting an overlooked or less-demanding segment and moving upmarket over time, not simply the act of finding an underserved niche.

But his work offers a useful explanation for why an incumbent's own strengths and discipline can create the opening a smaller entrant exploits. A founder does not need to outspend that discipline. A founder needs to find the position it is quietly leaving undefended.

When Capital Really Is the Moat

None of this holds in every market, and a fair account has to say so. There are industries where capital is not simply runway to be spent wisely or wasted. It is infrastructure, regulatory approval, manufacturing capacity, and working capital, all bought with money and reproducible by no amount of clever positioning. A biotech startup cannot position its way around the cost of clinical trials. A semiconductor company cannot out-message its way past the capital required to build or access fabrication capacity. Aerospace, energy infrastructure, and advanced manufacturing all carry similar floors, where a company simply cannot compete at all below a certain capital threshold, regardless of how sharply it has defined its market position.

The CB Insights failure data makes this visible from the other direction. Healthcare and biotech accounted for the largest share of both failures and capital destroyed in its dataset, $5.1 billion across 62 companies, a total inflated by the biotech subset reflecting the sheer capital intensity of clinical-stage drug development. Areteia Therapeutics raised $425 million before winding down after two of its late-stage asthma trials were terminated because, according to their listings on ClinicalTrials.gov, the benefit-risk profile no longer supported further development in the intended patient population. That is not a positioning failure in any meaningful sense. It is a case where the capital bought a real, well-funded shot at clearing a scientific and regulatory threshold the underlying biology ultimately did not clear.

The distinction that actually matters, then, is not whether capital helps. It always helps. It is what the capital is being asked to buy. When it buys infrastructure, trials, or manufacturing capacity that a competitor cannot easily reproduce, capital becomes part of the position itself, a moat in its own right. When it buys advertising, headcount, and additional months of runway before customers reject a product whose category was never clearly defined, it is much harder to distinguish real investment from an expensive delay.

What Founders Should Actually Build Before They Raise

None of the evidence here argues that capital is irrelevant. A validated position still needs resources to scale, defend, and hire around once competitors notice it works. What the evidence argues against is the sequencing many founders default to, in which a fundraise is treated as the first proof of legitimacy and positioning gets sorted out afterward, often under pressure from a board that has already priced in a bigger outcome than the market has agreed to yet. Quibi is close to what that sequencing looks like at its most extreme: the resources to build almost anything, arriving before the company had earned a specific place in anyone's daily habits.

The founders who beat larger, richer competitors tend to reverse that order where the market allows it. They identify one attribute or segment they can own more convincingly than anyone larger than them, resist broadening that position before it has actually taken hold, and let evidence of that ownership, rather than the size of their round, do the work of attracting the capital they eventually need. Where the market genuinely requires capital-as-infrastructure first, as in biotech or advanced hardware, that sequencing does not apply, and pretending otherwise is its own kind of mistake.

A December 2025 study using Chinese firm-registration data through 2024 found that generative AI tools were disproportionately increasing small-firm entry, with the effect strongest among first-time founders and companies with lower financing needs, while large-firm entry declined over the same period. If that pattern continues, it raises a genuine strategic question rather than settling one: as the cost of building certain products keeps falling, does capital become less differentiating, and does customer trust, distribution, proprietary data, or a defensible market position become relatively more important instead?

Which raises the question every founder chasing a round should probably sit with before the next pitch: if capital gets easier to raise and product gets cheaper to build, what exactly stops someone else from copying your company the moment it works? The answer cannot simply be more money. In a market where more of the building itself becomes affordable to everyone, the scarce advantage belongs to whichever company gives customers the clearest reason to choose it.

Also read - When the Crowd Isn't the Market: Parasocial Trust and the Cost of Mistaking Attention for Demand